Mozambique vs Tanzania: Access to anti-retroviral drugs, male
Mozambique
82.0%
in 2024
Tanzania
83.0%
in 2024
Mozambique rank
42nd
Tanzania rank
40th
Access to anti-retroviral drugs, male over time
- Mozambique
- Tanzania
How they compare
Tanzania currently reports 83.0% against 82.0% in Mozambique, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Tanzania ahead.
Mozambique ranks 42nd and Tanzania ranks 40th of 141 countries.
Tanzania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5% | 5.5% | 2.0% | Tanzania |
| 2010s | 30.7% | 34.9% | 4.2% | Tanzania |
| 2020s | 68.6% | 72.8% | 4.2% | Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Mozambique or Tanzania?
- Tanzania, at 83.0% against 82.0% in Mozambique as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Mozambique and Tanzania?
- 1.0%, with Tanzania ahead.
- How many years of comparable data are there for Mozambique and Tanzania?
- 25 years are reported by both, from 2000 to 2024.
- How do Mozambique and Tanzania rank globally for access to anti-retroviral drugs, male?
- Mozambique ranks 42nd and Tanzania ranks 40th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.